About
Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (36)
View allTotal Trials
36
As Lead Sponsor
30
As Collaborator
6
Total Enrollment
7,768
By Phase
PHASE3: 8PHASE1: 10PHASE2: 16PHASE1/PHASE2: 2
By Status
COMPLETED: 29TERMINATED: 4UNKNOWN: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline36 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06435221Lead Sponsor
Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers
PHASE3Active, not recruiting
650 participants
Started: May 28, 2024 · Completed: Dec 31, 2025
NCT05981768Lead Sponsor
Study to Evaluate Effect of Food on Bioavailability of Single 3 mg Tablet and Pharmacokinetics (PK) of Multiple 3 mg Doses in Healthy Adult Smokers
PHASE1Completed
30 participants
Started: Aug 8, 2023 · Completed: Sep 21, 2023
NCT05631938Lead Sponsor
Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose
PHASE1Completed
44 participants
Started: Jan 10, 2023 · Completed: Sep 4, 2023
NCT05566288Lead Sponsor
Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Healthy Smokers
PHASE1Completed
27 participants
Started: Oct 17, 2022 · Completed: Dec 23, 2022
NCT05431387Lead Sponsor
A Study of Cytisinicline for Vaping Cessation in Adult Smokers
PHASE2Completed
160 participants
Started: Jul 13, 2022 · Completed: Feb 28, 2023
Locations (1)
Headquarters
Vancouver, BC, Canada
Map
Loading map...